STERIS Market Cap 2010-2022 | STE

STERIS market cap history and chart from 2010 to 2022. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. STERIS market cap as of November 25, 2022 is $18.03B.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $18.026B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.198B 22.61
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Glaukos (GKOS) United States $2.248B 0.00
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00